Home
»
Frazier Life Sciences
Skip to content
FinSMEs
REAL TIME VC & PRIVATE EQUITY DEALS AND NEWS
Search for:
Facebook
Twitter
Linkedin
Navigation
Site navigation
USA
UK
Germany
France
Canada
India
Italy
Home
Frazier Life Sciences
Frazier Life Sciences
USA
Enlaza Therapeutics Raises $100M in Series A Financing
USA
Diagonal Therapeutics Launches with $128 Million in Financing
Germany
Tubulis Closes Upsized €128M Series B2 Funding
USA
Sudo Biosciences Raises Additional $30M in Series B; Brought Total Round to $147M
USA
Radionetics Oncology Closes $52.5M Series A Financing
USA
Lassen Therapeutics Closes $85M Series B Financing
USA
Sudo Biosciences Raises $116M in Series B Financing
USA
Carmot Therapeutics Raises $150M in Series E Equity Financing
USA
Enlaza Therapeutics Raises $61M in Seed Financing
USA
Alpha-9 Theranostics Raises $75M in Series B Financing
USA
Sudo Biosciences Raises $37M in Series A Financing
USA
Aspen Neuroscience Raises $147.5M in Series B Financing
Sign-up now to the Daily Newsletter